Covered recipient · General Payments record
JORDAN KIM
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2023
$1,620.98
- Reported across 106 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $562.90 | 33 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $272.28 | 17 |
| Novo Nordisk AS | $76.97 | 4 |
| Lilly USA, LLC | $58.33 | 4 |
| Abbott Laboratories | $39.47 | 2 |
| PFIZER INC. | $33.37 | 2 |
| Otsuka America Pharmaceutical, Inc. | $25.26 | 1 |
| Acerta Pharma LLC | $22.36 | 1 |
| GlaxoSmithKline, LLC. | $17.50 | 1 |
| Amgen Inc. | $17.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2023 2019202020212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.29 | 05/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018483535 | CMS |
| Abbott Laboratories | $23.18 | 10/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018513095 | CMS |
| ABBVIE INC. | $14.15 | 01/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997650487 | CMS |
| ABBVIE INC. | $18.78 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997650489 | CMS |
| ABBVIE INC. | $31.98 | 03/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997650491 | CMS |
| ABBVIE INC. | $25.65 | 04/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997650493 | CMS |
| ABBVIE INC. | $12.08 | 05/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997650495 | CMS |
| ABBVIE INC. | $10.59 | 05/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997650497 | CMS |
| ABBVIE INC. | $22.13 | 07/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997650499 | CMS |
| ABBVIE INC. | $3.22 | 08/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997650501 | CMS |
| ABBVIE INC. | $10.28 | 08/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997650503 | CMS |
| ABBVIE INC. | $27.66 | 09/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997650505 | CMS |
| ABBVIE INC. | $21.44 | 10/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997650507 | CMS |
| ABBVIE INC. | $14.64 | 10/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997650509 | CMS |
| ABBVIE INC. | $16.40 | 10/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997650511 | CMS |
| ABBVIE INC. | $15.61 | 11/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997650513 | CMS |
| ABBVIE INC. | $12.29 | 12/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997650515 | CMS |
| ABBVIE INC. | $7.95 | 12/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997650517 | CMS |
| ABBVIE INC. | $7.43 | 12/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997650519 | CMS |
| Amgen Inc. | $17.36 | 10/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020607237 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.36 | 08/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1011738381 | CMS |
| GlaxoSmithKline, LLC. | $17.50 | 08/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003196673 | CMS |
| Lilly USA, LLC | $16.06 | 02/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031639631 | CMS |
| Lilly USA, LLC | $14.73 | 03/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031639633 | CMS |
| Lilly USA, LLC | $14.03 | 08/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031684403 | CMS |
| Lilly USA, LLC | $13.51 | 09/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031527537 | CMS |
| Novo Nordisk Inc | $19.32 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002549381 | CMS |
| Novo Nordisk Inc | $20.74 | 03/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002549407 | CMS |
| Novo Nordisk Inc | $17.10 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002549369 | CMS |
| Novo Nordisk Inc | $19.81 | 08/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002549391 | CMS |
| Otsuka America Pharmaceutical, Inc. | $25.26 | 04/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014470269 | CMS |
| PFIZER INC. | $14.96 | 02/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049431797 | CMS |
| PFIZER INC. | $18.41 | 09/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049618875 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.